S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 40 of 56

Issue Date	Title / Author(s) / Citation	File
1997-03	Mutation of ras oncogene in gastric adenocarcinoma: Association with histological phenotype Kim, TY; Bang, YJ; Kim, WS; Kang, SH; Lee, KU; Choe, KJ; Kim, NK Anticancer Research, Vol.17 No.2B, pp.1335-1339
2001-01	CD99 regulates the transport of MHC class I molecules from the Golgi complex to the cell surface Sohn, Hae Won; Shin, Young Kee; Lee, Im-Soon; Bae, Young Mee; Suh, Young Ho; Kim, Min Kyung; Kim, Tae Jin; Jung, Kyeong Cheon; Park, Weon Seo; Park, Chan-Sik; Chung, Doo Hyun; Ahn, Kwang Seog; Kim, In Sun; Ko, Young Hyeh; Bang, Yung Jue; Kim, Chul Woo; Park, Seong Hoe Journal of Immunology, Vol.166 No.2, pp.787-794	DOI
2002-03	Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression Jong, Hyun-Soon; Lee, Ho Soon; Kim, Tae You; Im, Young-Hyuck; Park, Jae-Won; Kim, Noe Kyeong; Bang, Yung-Jue Biochemical and Biophysical Research Communications, Vol.292 No.2, pp.383-389	DOI
2002-08	p130 mediates TGF-β-induced cell-cycle arrest in Rb mutant HT-3 cells Choi, Hyun Ho; Jong, Hyun-Soon; Song, Sang Hyun; Kim, Tae You; Kim, Noe Kyeong; Bang, Yung-Jue Gynecologic Oncology, Vol.86 No.2, pp.184-189	DOI
2003-10	A novel ginseng saponin metabolite induces apoptosis and down-regulates fibroblast growth factor receptor 3 in myeloma cells Choi, Hyun Ho; Jong, Hyun-Soon; Park, Jung-Hyun; Choi, Seongwon; Lee, Jung Weon; Kim, Tae-You; Otsuki, Takemi; Namba, Masayoshi; Bang, Yung-Jue International Journal of Oncology, Vol.23 No.4, pp.1087-1093	DOI
2004-08	Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation Park, Jung-Hyun; Jung, Yeonjoo; Kim, Tai Young; Kim, Sang Gyun; Jong, Hyun-Soon; Lee, Jung Weon; Kim, Dae-Kee; Lee, Jong-Soo; Kim, Noe Kyeong; Kim, Tae You; Bang, Yung-Jue Clinical Cancer Research, Vol.10 No.15, pp.5271-5281	DOI
2004-09	AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity Choi, Moon-Chang; Jong, Hyun-Soon; Kim, Tai Young; Song, Sang-Hyun; Lee, Dong Soon; Lee, Jung Weon; Kim, Tae-You; Kim, Noe-Kyeong; Bang, Yung-Jue Oncogene, Vol.23 No.42, pp.7095-7103	DOI
2004-12	A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinoma Sun, Jong-Mu; Han, Wonshik; Im, Seock-Ah; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Bang, Yung-Jue; Choe, Kuk Jin; Kim, Noe Kyeong Cancer, Vol.101 No.11, pp.2516-2522	DOI
2005-01	Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa (R), ZD1839) in chemotherapy-resistant non-small cell lung cancer Han, Sae-Won; Hwang, Pil Gyu; Chung, Doo Hyun; Kim, Dong-Wan; Im, Seock-Ah; Kim, Young Tae; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong International Journal of Cancer, Vol.113 No.1, pp.109-115	DOI
2005-03	Cyclooxygenase-2 inhibits novel ginseng metabolite-mediated apoptosis Yim, Hyung Woo; Jong, Hyun-Soon; Kim, Tai Young; Choi, Hyun Ho; Kim, Sang Gyun; Song, Sang Hyun; Kim, Juyong; Ko, Seong-Gyu; Lee, Jung Weon; Kim, Tae-You; Bang, Yung-Jue Cancer Research, Vol.65 No.5, pp.1952-1960	DOI
2005-08	Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): Phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor Im, Seock-Ah; Kim, Sung-Bae; Lee, Moon Hee; Im, Young-Hyuck; Lee, Kyung Gee; Song, Hong-Suk; Lee, Myung-Ah; Lee, Junglim; Lee, Nam-Su; Ham, Hae Sun; Kim, Tae-You; Park, Yeon Hee; Lee, Kyung Eun; Kim, Kee Won; Seo, Jae Hong; Lee, Soon Nam; Hong, Young Seon; Bang, Yung-Jue; Kim, Woo-Kun; Park, Hee-Sook Oncology Reports, Vol.14 No.2, pp.481-487	DOI
2006-08	Primary systemic anaplastic large cell lymphoma in a single Korean institution: Clinical characteristics and treatment outcome Park, Sook Ryun; Baek, Ji Yeon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Kim, Noe Kyeong; Jeon, Yoon Kyung; Kim, Chul Woo; Heo, Dae Seog Journal of Korean Medical Science, Vol.21 No.4, pp.633-638	view file DOI
2006-12	Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells Lee, Ju-Hee; Park, Jung-Hyun; Jung, Yeonjoo; Kim, Jee-Hyun; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.5 No.12, pp.3085-3095	DOI
2007-04	Zinc-fingers and homeoboxes 1 (ZHX1) binds DNA methyltransferase (DNMT) 3B to enhance DNMT3B-mediated transcriptional repression Kim, Sung-Hak; Park, Jinah; Choi, Moon-Chang; Kim, Hwang-Phill; Park, Jung-Hyun; Jung, Yeonjoo; Lee, Ju-Hee; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Biochemical and Biophysical Research Communications, Vol.355 No.2, pp.318-323	DOI
2007-05	Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer Han, Sae-Won; Jeon, Yoon Kyung; Lee, Kyung-Hun; Keam, Bhumsuk; Hwang, Pil Gyu; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue; Kim, Tae-You Pharmacogenetics and Genomics, Vol.17 No.5, pp.313-319	DOI
2007-11	Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer Keam, Bhumsuk; Im, Seock-Ah; Kim, Hee-Jun; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue BMC Cancer, Vol.7, p. 203	view file DOI
2008-01	Inhibitors of histone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinase Park, Jung-Hyun; Jong, Hyun-Soon; Kim, Sang Gyun; Jung, Yeonjoo; Lee, Keun-Wook; Lee, Ju-Hee; Kim, Dae-Kee; Bang, Yung-Jue; Kim, Tae-You Journal of Molecular Medicine, Vol.86 No.1, pp.117-128	DOI
2008-02	Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers Jung, Yeonjoo; Park, Jinah; Bang, Yung-Jue; Kim, Tae-You Laboratory Investigation, Vol.88 No.2, pp.153-160	DOI
2008-03	Enzastaurin, a protein kinase Cβ inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells Lee, Keun-Wook; Kim, Sang Gyun; Kim, Hwang-Phill; Kwon, Euna; Yons, Jiran; Choi, Hyung-Jun; Park, Jung-Hyun; Kang, Byeong-Cheol; Im, Seock-Ah; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Cancer Research, Vol.68 No.6, pp.1916-1926	DOI
2008-05	A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker Keam, Bhumsuk; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue Molecular Medicine Reports, Vol.1 No.3, pp.415-422	DOI
2008-08	A-kinase anchoring protein 12 regulates the completion of cytokinesis Choi, Moon-Chang; Lee, Yang-Ui; Kim, Sung-Hak; Park, Jung-Hyun; Kim, Hyun-Ah; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Jong, Hyun-Soon; Bang, Yung-Jue Biochemical and Biophysical Research Communications, Vol.373 No.1, pp.85-89	DOI
2008-10	The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer Rhee, Jiyoung; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Bang, Yung-Jue; Kim, Tae-You BMC Cancer, Vol.8, p. 307	view file DOI
2008-12	Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cells Kim, Tai Young; Kim, In Sook; Jong, Hyun-Soon; Lee, Jung Weon; Kim, Tae-You; Jung, Mira; Bang, Yung-Jue Experimental and Molecular Medicine, Vol.40 No.6, pp.639-646	DOI
2009-01	Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer Han, S-W; Oh, D-Y; Im, S-A; Park, S. R.; Lee, K-W; Song, H. S.; Lee, N-S; Lee, K. H.; Choi, I. S.; Lee, M. H.; Kim, M. A.; Kim, W. H.; Bang, Y-J; Kim, T-Y British Journal of Cancer, Vol.100 No.2, pp.298-304	DOI
2009-10	Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: Eukaryotic elongation factor 1A2 as a potential target Lee, Mee-Hyun; Choi, Bu Young; Kundu, Joydeb Kumar; Shin, Young Kee; Na, Hye-Kyung; Surh, Young-Joon Cancer Research, Vol.69 No.18, pp.7449-7458	DOI
2010-06	DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells Kim, Heesun; Park, Jinah; Jung, Yeonjoo; Song, Sang-Hyun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You International Journal of Oncology, Vol.36 No.6, pp.1563-1572	DOI
2010-06	The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancer Sun, Jong-Mu; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Lee, Jong Seok; Kim, Young-Whan; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.68 No.3, pp.427-432	DOI
2010-08	Inhibition of Histone Deacetylase 10 Induces Thioredoxin-Interacting Protein and Causes Accumulation of Reactive Oxygen Species in SNU-620 Human Gastric Cancer Cells Lee, Ju-Hee; Jeong, Eun-Goo; Choi, Moon-Chang; Kim, Sung-Hak; Park, Jung-Hyun; Song, Sang-Hyun; Park, Jinah; Bang, Yung-Jue; Kim, Tae-You Molecules and Cells, Vol.30 No.2, pp.107-112	DOI
2010-09	Salivary chemokine levels in patients with primary Sjogren's syndrome Lee, Yun Jong; Scofield, Robert H.; Hyon, Joon Young; Yun, Pil Young; Lee, Hyo Jung; Lee, Eun Young; Lee, Eun Bong; Song, Yeong Wook Rheumatology, Vol.49 No.9, pp.1747-1752	DOI
2010-10	Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less Kwon, Ji Hyun; Kim, Yu Jung; Lee, Keun-Wook; Oh, Do-Youn; Park, So Yeon; Kim, Jee Hyun; Chie, Eui Kyu; Kim, Sung-Won; Im, Seock-Ah; Kim, In-Ah; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Bang, Yung-Jue; Ha, Sung Whan BMC Cancer, Vol.10, p. 557	view file DOI
2010-12	RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase Lee, Kyung-Hun; Hur, Hyung-Seok; Im, Seock-Ah; Lee, Juhee; Kim, Hwang-Phill; Yoon, Young-Kwang; Han, Sae-Won; Song, Sang-Hyun; Oh, Do-Youn; Kim, Tae-You; Bang, Yung-Jue Cancer Letters, Vol.299 No.1, pp.22-28	DOI
2011-03	Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis Keam, Bhumsuk; Im, Seock-Ah; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Bang, Yung-Jue Breast Cancer Research, Vol.13 No.2, p. R22	view file DOI
2011-06	Clinicopathologic characteristics of patients with stage III/IV (M 0) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization Im, Seock-Ah; Kim, Jin Won; Kim, Jin-Soo; Kim, Min A.; Jordan, Bruce; Pickl, Marlene; Han, Sae-Won; Oh, Do-Youn; Lee, Hyuk Joon; Kim, Tae-You; Kim, Woo Ho; Yang, Han-Kwang; Bang, Yung-Jue Diagnostic Molecular Pathology, Vol.20 No.2, pp.94-100	DOI
2011-07	Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins Lee, Kyung-Hun; Lee, Ju-Hee; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Cancer Science, Vol.102 No.7, pp.1388-1395	DOI
2011-10	Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer Park, Jin Hyun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Jeong, Seung-Yong; Park, Kyu Joo; Kim, Tae-You; Bang, Yung-Jue; Park, Jae-Gahb Cancer Chemotherapy and Pharmacology, Vol.68 No.4, pp.1045-1055	DOI
2012-07	Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers Yun, Jiyeon; Song, Sang-Hyun; Park, Jinah; Kim, Hwang-Phill; Yoon, Young-Kwang; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Laboratory Investigation, Vol.92 No.7, pp.1033-1044	DOI
2012-08	Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer Park, Jinah; Park, Eunju; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Kim, Woo-Ho; Oh, Do-Youn; Bang, Yung-Jue Investigational New Drugs, Vol.30 No.4, pp.1404-1412	DOI
2013-07	OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells Kim, Mi-Jung; Nam, Hyun-Jin; Kim, Hwang-Phill; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Cancer Letters, Vol.335 No.1, pp.145-152	DOI
2014-06	Testican-1-mediated epithelial-mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer Kim, H-P; Han, S-W; Song, S-H; Jeong, E-G; Lee, M-Y; Hwang, D.; Im, S-A; Bang, Y-J; Kim, T-Y Oncogene, Vol.33 No.25, pp.3334-3341	DOI
2014-08	Immunohistochemical Features Associated with Sensitivity to Lapatinib-plus-Capecitabine and Resistance to Trastuzumab in HER2-positive Breast Cancer Cha, Yongjun; Han, Sae-Won; Seol, Hyesil; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Park, In Ae; Han, Wonshik; Noh, Dong-Young; Kim, Tae-You Anticancer Research, Vol.34 No.8, pp.4275-4280

1 2